Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078897 · ClinicalTrials.gov registry record · Phase 3
Selenium for Prevention of Adenomatous Colorectal Polyps
A Phase 3 study, sponsored by University of Arizona.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1,621
- Enrollment target
NCT00078897 is a Phase 3 study that was terminated before completion, run by University of Arizona. The registered enrollment target is 1,621 participants.
The verdict
NCT00078897, a Phase 3 study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1,621 participants
- Enrollment target
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Selenium may be effective in preventing the recurrence of adenomatous colorectal polyps. PURPOSE: This randomized phase III trial is studying selenium to see how well it works in preventing the recurrence of polyps in patients with adenomatous colorectal polyps.
Interventions
- DRUG Selenium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,621 participants |
| Start Date | 2005-01-20 |
| Est. Completion | 2018-05-17 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00078897
The ClinicalTrials.gov registry entry for NCT00078897 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 1,621 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Selenium is the first listed.
NCT00078897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00078897 about?
NCT00078897 is a clinical study titled "Selenium for Prevention of Adenomatous Colorectal Polyps". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Selenium may be effective in preventing the recurrence of adenomatous colorectal polyps. PURPOSE: This randomized phase III trial is studying selenium to see how well it works i...
What is the current status of trial NCT00078897?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1,621 participants. The study started on 2005-01-20. Estimated completion is 2018-05-17.
What interventions are being tested in trial NCT00078897?
The interventions under investigation include: Selenium (DRUG).
Who is sponsoring clinical trial NCT00078897?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.